SEC Form 4 · accession 0001209191-15-082005
CONVERGYS CORP · CVG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey H Fox
Director
Period of report
Nov 20, 2015
Accepted (ET)
Nov 24, 2015 · 4:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062047
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Nov 20, 2015 | M | 10,000 | $12.79 | A | 394,355 | D | |
| Common SharesF1 | Nov 20, 2015 | S | 10,000 | $25.136 | D | 384,355 | D | |
| Common SharesF2 | Nov 20, 2015 | S | 10,000 | $25.059 | D | 30,000 | I | By Fox Family Charitable Trust |
| Common Shares | Nov 23, 2015 | M | 10,218 | $12.79 | A | 394,573 | D | |
| Common SharesF3 | Nov 23, 2015 | S | 10,218 | $25.4828 | D | 384,355 | D | |
| Common SharesF4 | Nov 23, 2015 | S | 5,000 | $25.5715 | D | 25,000 | I | By Fox Family Charitable Trust |
| Common Shares | Nov 23, 2015 | M | 10,000 | $12.79 | A | 394,354 | D | |
| Common SharesF5 | Nov 23, 2015 | S | 10,000 | $25.6567 | D | 384,355 | D | |
| Common Shares | holding | — | — | — | 350,000 | I | By FAMCO Enterprises Limited |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F6 | $12.79 | Nov 20, 2015 | M | 10,000 | D | — | — | Common Shares | 10,000 | 196,588 | D |
| Stock Options (Right to Buy)F6 | $12.79 | Nov 23, 2015 | M | 10,218 | D | — | — | Common Shares | 10,218 | 186,370 | D |
| Stock Options (Right to Buy)F6 | $12.79 | Nov 23, 2015 | M | 10,000 | D | — | — | Common Shares | 10,000 | 176,370 | D |
Explanation of responses
- F1The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.04 to $25.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote to this Form 4.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.02 to $25.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote to this Form 4.
- F3The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.475 to $25.565, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote to this Form 4.
- F4The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.565 to $25.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote to this Form 4.
- F5The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.61 to $25.685, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote to this Form 4.
- F6The stock options were part of a previously reported grant with a two year vesting, 50% on February 10, 2014 and 50% on February 10, 2015, that expires on February 10, 2022.